This website is an international information resource intended for international healthcare professionals outside the United States of America (US) and the United Kingdom (UK) who are interested in information about Boehringer Ingelheim oncology.
While the Internet serves a global community, the pharmaceutical industry is subject to country-specific regulatory considerations. This means that compound status or the registration status and approved product labels of Afatinib or Nintedanib may not be the same in different countries.
Information about approved products on this website is derived from the Summary of Product Characteristics (SPC) for Afatinib and Nintedanib in the EU. It is not country-specific and may vary from the approved label in the country where you are located. Please refer to your local Prescribing Information for full details.
By clicking on the link below you are declaring and confirming that you are a healthcare professional outside the United States of America and the United Kingdom and have read and understood this disclaimer.
Accessibility Statement for Boehringer Ingelheim websites
Boehringer Ingelheim is committed to providing a website that is accessible to the widest possible audience, regardless of technology or ability. We are actively working to increase the accessibility and usability of our website and in doing so adhere to many of the available standards and guidelines. These guidelines explain how to make web content more accessible for people with disabilities. Conformance with these guidelines will help make the web more user friendly for all people. We are continually seeking out solutions that will bring all areas of the site up to the same level of overall web accessibility.
Multimedia elements: Images, video and audio files
Alternative and short descriptive texts are available for all multimedia and non-text content. A simplified version of the site is also available, displaying a page with descriptive texts in the place of all images and videos. All videos and multimedia give a size indication, so that downloading time can be estimated. If software is required to view the videos, a plug in download link will be posted. An HTML substitute for Flash Player will also be provided for future videos. All videos will be presented with player software which enables the user to play, pause, stop, forward and rewind the video. Live webcasts will be archived after broadcasting to be available for a later viewing. No flashing content will be provided.
Presentation of Content and Layout
There is a strict separation of content and layout via the proper use of HTML and CSS (Cascading Style Sheet). Layout tables are avoided where possible.
We are focusing on structuring items, making it possible to scan through a document and giving air to long texts. This includes:
We try to offer a clear navigation structure that helps you to find the content you are looking for in an easy and quick way.
Links contain title attributes which describe content and make sense out of context.
The use of short sentences and paragraphs and multiple entry points to additional information sources e.g. via teaser elements and related content areas will make it easier to comprehend the content.
In the meantime, should you experience any difficulty in accessing the Boehringer Ingelheim Corporate Website, please do not hesitate to contact us.
Using this link will let you leave a website of Boehringer Ingelheim International GmbH (“BI”) or to a different domain under the control of BI. In the event that the linked site is not under the control of BI but under the control of a third party or an affiliate in the Boehringer Ingelheim group of companies, BI shall not be responsible for the contents, processing of personal data of any linked site or any link contained in a linked site, or any changes or updates to such sites. This link is provided to you only as a convenience, and the inclusion of any link does not imply endorsement by BI of the site.
Do you want to continue ?Continue